glp-1 side effects cancer Receptor Agonists in Breast Cancer: A New Frontier in Obesity and Prognosis Management The Impact and Safety of

4 A history of gallbladder disease A 2022 systematic review of 76 randomised trials found that GLP-1 medications are associated with a relative risk of around 37% for gallbladder or biliary disease, with a higher relative risk in weight-loss trials than in diabetes trials

So there's Liraglutide, which is a daily injection

It is a once-daily subcutaneous injection

Curr Atheroscler Rep 27 , 99 (2025)

They may share the same active ingredient, but theyre prescribed as different brands for different usages

Employers that plan for change and build the right support around these medications are better positioned to deliver outcomes and contain costs